Tiedote -
Closed System Transfer Device Market Size, Growth Insights and Forecasts to 2027
Precedence Research has published a new report titled “Closed System Transfer Device Market Size, Share By Type (Needleless Systems and Membrane-to-Membrane Systems), By Closing Mechanism (Color-To-Color Alignment Systems, Push-To-Turn Systems, Click-To-Lock Systems, and Luer-Lock Systems), By Component (Syringe Safety Devices, Vial Access Devices, Accessories, and Bag/Line Access Devices), By End User (Clinics & Oncology Centers, Hospitals, and Others) - Global Industry Analysis, Growth, Trends Analysis, Segment Forecasts, Regional Outlook 2020 - 2027”, the closed system transfer device market revenue is projected to reach US$ 1,620.6 million by 2027, registering a CAGR of 20.6% from 2020 to 2027.
The report provides many business organizations with the required information to proliferate their business’ reach within the global closed system transfer device market. The report provides the overall revenue of the global closed system transfer device market from 2016 to 2027, considering 2020 as the base year and 2027 as the forecast year.
Download a Sample Copy with TOC, Graphs & List of Figures @ https://www.precedenceresearch.com/sample/1180
Growth Factors:
Factors such as growing prevalence of cancer and rising need for monitoring compliance for harmless handling of damaging drugs are driving the growth of closed system transfer device market. Antineoplastic drugs, also known as anticancer drugs, are life-saving for cancer patient. However, these drugs can also be detrimental to the health of the medical professionals. This can occur if the drugs escape during compounding, rebuilding or delivery to patients. At the oncology center, the pharmacy specialists prepare all quantities of chemotherapy under the direction of the expert pharmacist. The CSTDs (Closed system drug transfers devices) are very well known for efficiency at decreasing surface adulteration and contact of healthcare workers after execution. CSTDs are thus necessary for such medicinal preparations. Growing prevalence of cancer all over the world has heavily amplified the demand for the closed system drug transfer devices. Globally, cancer prevalence rate has amplified to make it the second chief cause of demise after cardiovascular disease.
Hazardous drugs, specifically the subclasses of antineoplastic medications, have been designated as the highest chemical hazard existing in the health field and one of the furthermost dangerous chemical agents ever made. Establishments focused on industrial safety, such as the Occupational and Safety and Health Administration (OSHA), Joint Commission, and the Pan American Health Organization (PAHO) are offering increasing consideration to recommendations and tactics for improving protection regarding harmful drugs.
Report Highlights:
- Among the type segment, membrane-to-membrane systems are expected to dominate the overall market. Membrane-to-membrane systems have multiple advantages over other systems which makes them a system of choice in many settings.
- The push-to-turn systems accounted for the largest revenue in the closing mechanism segment with more than 34% share in 2019. Increasing awareness regarding the use of push-to-turn systems for safe transfer of drugs is the major reason for high market share of push-to-turn systems. Luer-lock systems are expected to grow at the topmost CAGR during the forecast time-frame.
- Vial access devices accounted for the largest revenue in the component segment. High usage frequency is the key reason for high market share of vial access devices.
- Hospitals accounted for the largest revenue in the end-user segment. High frequency of chemotherapy administration in hospitals is the key reason for high market share of hospitals.
- ICU Medical, Inc. accounted for a significant share of the global closed system transfer device market.
Regional Analysis:
The report covers data for North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. In 2019, North America dominated the global market with a market share of more than 42%. U.S. represented the highest share in the North American region primarily due to presence of leading market players and high awareness regarding drug safety. Furthermore, early adoption of latest healthcare technologies also contributed to the high market share of the United States.
Europe was the second important market chiefly due to presence of latest healthcare infrastructure and high investment in research and development. The presence of skilled researchers in the European region is also expected to boost the demand for closed system transfer device market in the near future. Asia Pacific is anticipated to grow at the maximum CAGR of around 18% in the forecast period due to high incidence of cancer. Latin America and the African and Middle Eastern region will display noticeable growth.
COVID-19 Impact on closed system transfer device market sales
Businesses today are operating in a dynamic environment. Earlier focus primarily concentrated on keeping pace with changing consumer preferences. COVID-19 outbreak was unprecedented and exposed vulnerabilities of various industries. Pandemic-induces obstacles also were registered in the closed system transfer device market.
Sales plummeted as COVID-19 gradually tightened its noose worldwide. Supply-chain disruptions caused massive losses, while demand took nose-dive as consumers remained indoors with affected countries implementing either partial or complete lockdown.
Gradual recovery however is on the cards with the roll out of vaccinations. Nonetheless, consecutive waves of the virus compelled businesses to stay prepared for the worst. As government and healthcare organizations successfully implement steps to contain the spread of COVID-19, industries have begun operations, albeit at a slow and more cautious pace.
Against this backdrop, Precedence Research’s study predicts gradual recovery for the closed system transfer device market from 2021 onwards. This trend will however continue through the course of the report’s assessment period
Key Market Players and Strategies:
The major companies operating in the worldwide closed system transfer device are Baxter International Inc., Becton, Dickinson, and Company, CodanMedizinischeGeräte GmbH & Co Kg, ICU Medical, Inc., Yukon Medical, B. Braun Melsungen, Equashield, Teva Pharmaceutical Industries Ltd., Victus, Inc., and Corvida Medical among others.
High investment in the research and development along with acquisition, mergers, and collaborations are the key strategies undertaken by companies operating in the global closed system transfer device market. Arisure closed system transfer device from Baxter helps in preventing hazardous drug exposure and maintain medication sterility. The Arisure CSTD is designed to be simple to use with an importance towards safety.
Major Market Segments Covered:
By Type
- Needleless Systems
- Membrane-to-Membrane Systems
By Closing Mechanism
- Color-To-Color Alignment Systems
- Push-To-Turn Systems
- Click-To-Lock Systems
- Luer-Lock Systems
By Component
- Syringe Safety Devices
- Vial Access Devices
- Accessories
- Bag/Line Access Devices
By End User
- Clinics & Oncology Centers
- Hospitals
- Others
By Geography
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- United Kingdom
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Southeast Asia
- Rest of Asia Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC
- North Africa
- South Africa
- Rest of Middle East & Africa
Why Buy this Report?
The purpose of Precedence Research's closed system transfer device market study is to provide stakeholders with a detailed picture of potential barriers and untapped opportunities. The report contains exclusive information to assist businesses in making informed decisions about how to maintain growth throughout the assessment period.
Buy Full Research Report (Single User License US$ 4999) @ https://www.precedenceresearch.com/checkout/1180
About Us
Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semiconductors, chemicals, automotive, and aerospace & defense, among different ventures, present globally.
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Aiheet
- Urakointi, koneet
Kategoriat
- closed system transfer device market